ORF_ID	CONTIG	START	STOP	ORIENTATION	CUT_OFF	PASS_EVALUE	Best_Hit_evalue	Best_Hit_ARO	Best_Identities	ARO	ARO_name	Model_type	SNP	Best_Hit_ARO_category	ARO_category	PASS_bitscore	Best_Hit_bitscore	bit_score	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	LABEL	ID	Model_id
BGC0000286.1|Viguiepinol_4	ID=1_4;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.680	4094	5176	+	Loose	n/a	8.89423	SFH-1	34.15	ARO:3000849, ARO:3000491	SFH-1, acrD	protein homolog model	n/a	antibiotic inactivation enzyme; determinant of beta-lactam resistance	antibiotic inactivation enzyme; determinant of beta-lactam resistance; efflux pump complex or subunit conferring antibiotic resistance	2100	24.2534	24.2534, 24.6386	ATGAGCCCCACCACCAGCCTTCACGAGCTGGGATCCGGCGTCCTGGACTCGGTTCATCTGCGCGGCCTGATCGACGAAAGACTGAACGCCTTCCTCGACGCCAAGTCCGGCAGGGACACGGATGTCCACCTGGTCTCGCTCATCGAGCACCTGCGTGACTTCCTGGCCGCGGGCGGCAAGCGCATACGGCCGCTCTTGTGCATGGTGGGCTGGCACGCGGCGGGAGGATACGGCGAAACGGAGCCCATCATCGGCGCGGCGGCCTCGCTCGAACTCTTCCACGCCTTCACCCTCATCCATGACGACGTGATGGACGCCTCCGACACCCGGCGCGGCCGTCCGACCCTTCACCGCACGCTGGAGACGGGTGCGAACGGCACGACCGCCGAGCGGTTCGGCACCAACAGCGCGATCCTGCTCGGCGACCTGGTCATGGTGTGGTCGGACGAGCTGCTGTACTCAAGCGGCCTCGACCAGCAGCAACTGGTCGCCGTTCGACCGCTGTTGGACGCCATGCGTACCGAGGTGATGATCGGTCAGTACCGGGATCTGCTGTCCACCGGGCAGCCCACCGCGGACGTCGAACGGTCGCTGGCAGTGATCCGCTACAAAACGGCCAAGTACACCGTGGAGCGGCCGCTGCACATCGGCGCGGCCCTTGCCGGAGCGGACCAGTCCCTGCTGGACGTCTGCACCGCCTACGCTCTTCCGATCGGAGAGGCCTTCCAACTGCGCGACGACCTGCTCGGCGTCTTCGGCGACCCGTCCAAGACCGGCAAGTCGACCCTGGACGACCTGCGGGAGGGCAAAGCGACAGCCCTGATGGCGCACGCCCTCCACACCGCCGGCACCGAGCAGGCGCGGGTGCTGAGGTCCCTGGTCGGCGACCCGGACCTGGACGAAGCAGGCGCCGAGACGGTCCGCGGGGTTCTACGGGCCACGGGCGCCGCCGACAAGGTGGAGCAGATGATCACCGATCGGGTGCAGCGTGCCCGGCGGGTCCTGGACGAGGCCCCGTTCCCGGACGAGGTCAAGAAGACCCTCGACACCTTCGTCACCACCACCACGCTCAGGACCACCTGA	MSPTTSLHELGSGVLDSVHLRGLIDERLNAFLDAKSGRDTDVHLVSLIEHLRDFLAAGGKRIRPLLCMVGWHAAGGYGETEPIIGAAASLELFHAFTLIHDDVMDASDTRRGRPTLHRTLETGANGTTAERFGTNSAILLGDLVMVWSDELLYSSGLDQQQLVAVRPLLDAMRTEVMIGQYRDLLSTGQPTADVERSLAVIRYKTAKYTVERPLHIGAALAGADQSLLDVCTAYALPIGEAFQLRDDLLGVFGDPSKTGKSTLDDLREGKATALMAHALHTAGTEQARVLRSLVGDPDLDEAGAETVRGVLRATGAADKVEQMITDRVQRARRVLDEAPFPDEVKKTLDTFVTTTTLRTT	MASEKNLTLTHFKGPLYIVEDKEYVQENSMVYIGTDGITIIGATWTPETAETLYKEIRKVSPLPINEVINTNYHTDRAGGNAYWKTLGAKIVATQMTYDLQKSQWGSIVNFTRQGNNKYPNLEKSLPDTVFPGDFNLQNGSIRAMYLGEAHTKDGIFVYFPAERVLYGNCILKENLGNMSFANRTEYPKTLEKLKGLIEQGELKVDSIIAGHDTPIHDVGLIDHYLTLLEKAPK	BGC0000286.1|Viguiepinol_4#4095#5177#1#ID=1_4;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.680	gnl|BL_ORD_ID|3|hsp_num:0	347
BGC0000286.1|Viguiepinol_16	ID=1_16;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.745	16428	17861	+	Loose	n/a	0.525766	tetX	43.75	ARO:3000205, ARO:3002884	tetX, iri	protein homolog model	n/a	antibiotic inactivation enzyme; determinant of tetracycline resistance	antibiotic inactivation enzyme; determinant of rifamycin resistance; determinant of tetracycline resistance	900	28.4906	28.4906, 27.335	GTGACCGGGCCCGTCGTGGTGGGCGGCAGCGTCGCGGGGCTCGCCGCCGGCCTCGCCCTGGCGTTACGGGGCCTGCCCGTCCGGGTGCTGGAGCAGGCGCCCGTACCGCCGGAAGGGCCGCCGGGGAAGGCGGCCGAGCTGTGGAAGAGGCCCACTGTCGCGCAGAACGGCCACTCCCACGTCCTGACCTCGCTCGGCGTACGGGTGCTGCGGGCCCACGTCCCTCAGGTGCTCGACGCCGCTTTGGAGGCCGGCGCACGCATGCTCGACCTCATGCGGGCGCTGCCGGTACGGGCCGACGATGGGATCCGCCGCCAGGGCGACGAGGAACTCGTGGCCCTCGCCGTGCGCCGCCCGGTCTTCGAACTCGTCCTCCGCCAGGCGCTGCGGTCGCTGCCGAACGTCACGATCAGCCATGACGTCAAGGTCATAGGCCTGCGCACGACGCCCTCGGGGAACCGGGTGACGGGCCTGGTGACCGGCGACGGCGAGGACATCCCCACGCATACGGTCGTGGACGCCACCGGACGCCGGTCGGCGTCGCGGTCCTGGCTCACCGCCGCCGGATTTCCCCCGGAAGCCGCGAGGACCGCCCCCACCCGGGTGCGCGCCTTCACCCGCTTCTACCGGCTCAGGTCCCCCGGCACGCTGCCCGGACCGCTCAACCGCGGCAACGCGGCGGGCGGCATCTGGGACCACTACGCGGCGGTCGCACACCTCGCCGACAACGACACGTACGCCCTGACCGTCGGCGTGCCCACTGCGGATCCGGCGACGACAGGCCTGCGGCATCCGGCCGCCTTCACCGCGGTCGCCCGTCTTTCGCCGTACCTCGCCGCCTGGGCCGATCCCGCGGTGGGGGAGCCGATCAGCGCGGTGCGAGCCATCACCCTGCCGCCCAACACGCTGCACTGCGCACCCGACGCCGGCGCCGGGCCGATCGCGGGCCTGTACCCGGTCGGGGACGCCGCGTGTGTCACCGACCCGCTCTTCGGGCGGGGCATGTCGCTGGCCCTGCGGCACGCTTTCCTGCTCGCGGATTTCCTGGCGGACGAGCCGGCGGTCGAGGAGCAGGGTGAACGTGCCGCACGCATCGCCGACGGCGTCTACCGGTCGTGGTACGAGCAGTCCGTCCGCGAGGACGCGGCACGCACGGCCCTGTGGCAGGCGAGGGTCACGGGATGCCCGCCGCCGACGGTATCGGAGTCCGGCCGCGCAGCACTGTCCGAAGTCGCCCGGGCGGCGGCCGCCGACGGGACCGTGTGGCGCGGCCTCACCCGCGTGCTGATGGGCCTGGAGACCGTCGAGGACGTCTTCGACGACGAGGCGTTCCGCCGACGGGTACGGACGGCCCCCGAACCGGCCGCGGCCGCGCCGCGCCCACTGACGCGGGAGGAACTGGTCGCCGCCGTCAGAGACGAGGTGCGCGCATGA	VTGPVVVGGSVAGLAAGLALALRGLPVRVLEQAPVPPEGPPGKAAELWKRPTVAQNGHSHVLTSLGVRVLRAHVPQVLDAALEAGARMLDLMRALPVRADDGIRRQGDEELVALAVRRPVFELVLRQALRSLPNVTISHDVKVIGLRTTPSGNRVTGLVTGDGEDIPTHTVVDATGRRSASRSWLTAAGFPPEAARTAPTRVRAFTRFYRLRSPGTLPGPLNRGNAAGGIWDHYAAVAHLADNDTYALTVGVPTADPATTGLRHPAAFTAVARLSPYLAAWADPAVGEPISAVRAITLPPNTLHCAPDAGAGPIAGLYPVGDAACVTDPLFGRGMSLALRHAFLLADFLADEPAVEEQGERAARIADGVYRSWYEQSVREDAARTALWQARVTGCPPPTVSESGRAALSEVARAAAADGTVWRGLTRVLMGLETVEDVFDDEAFRRRVRTAPEPAAAAPRPLTREELVAAVRDEVRA	MTMRIDTDKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDLHKGSGQEAMKKAGLLQTYYDLALPMGVNIADKKGNILSTKNVKPENRFDNPEINRNDLRAILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVILANGGMSKVRKFVTDTEVEETGTFNIQADIHQPEINCPGFFQLCNGNRLMASHQGNLLFANPNNNGALHFGISFKTPDEWKNQTQVDFQNRNSVVDFLLKEFSDWDERYKELIHTTLSFVGLATRIFPLEKPWKSKRPLPITMIGDAAHLMPPFAGQGVNSGLVDALILSDNLADGKFNSIEEAVKNYEQQMFMYGKEAQEESTQNEIEMFKPDFTFQQLLNV	BGC0000286.1|Viguiepinol_16#16429#17862#1#ID=1_16;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.745	gnl|BL_ORD_ID|1398|hsp_num:0	776
BGC0000286.1|Viguiepinol_3	ID=1_3;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.700	2989	3876	+	Loose	n/a	0.217693	cpxA	25.32	ARO:3000830	cpxA	protein homolog model	n/a	efflux pump complex or subunit conferring antibiotic resistance; protein(s) and two-component regulatory system modulating antibiotic efflux	efflux pump complex or subunit conferring antibiotic resistance; protein(s) and two-component regulatory system modulating antibiotic efflux	890	28.8758	28.8758	ATGCGTGCCCGTCACCGTGTGGCGCTGAAGGTCCTGGCCGATCTGCGGTCCTGGGCGGCGGAATACCCGCAGGTCCTCGAGGCCACGCCGATCGAAGCCCTGGCGATCTCCACCGCGGCGATCAGCCCGTGGCGCGGAGCGAACGAGCTCCGGCTGTCGGCCCCGGATGTACGCTGTGGGCCTACGCCCCTGGACGACCACGTCGAGCAGAACGTCCGGAGCCTCGACGAACTCGACGACCTGTTCGGTCGCTGCGAGGCCATCGTCCGGGGCGGCGACCGGGACGACGGCCATCCCCTGCTGGCCTCCCTGTCCGGCTGGCAGTCCGCTTTGGAGCGGGCTCCCCACTACCCGAAACTGGCCGGCCTGTGGGGCGACCGATTCGCCGAGGCCCTGCGCGGCGAGCGGTACGACTGGACCGCGGGTCTGGCCAGGGACCGCGGCGAGGGCCCTTCCGATCCGCAGGAGTACCTGACGTACGCCGCCAGCTCCAATGCGTGGATAACCCACTTCCCGCGCTGGGCGACCAGCGACCGGGACGATCTCCTCGATGGCCTGCCGGTCCTGGACAACGCCCTGGAGGCGATCGAAGTCGCCGTGCGCCTCTCCAACGACCTGGCCACCTTCGAGCGGGAGCGGGCCGAGCCCGGTCAGAACAACATCCTGATGTACGACACCTCACCCGACTGGGTGCACGACGAACTCGACCGGCATTCCCGCAAGGCGCAGGAGCAGCTCGACCCGCTGGCGACGGCCGGGTTCCCACCCGCTGTCGAGCTGCTCCGCCTGCTCGATTGGTCGGTCACCTTCTACAGCGGCGCCGACTTCCGGGGATGGGGATCCGACCGCGATCTCACCGGGCCGTCCGGCCTGCCCTCCGACATGTGA	MRARHRVALKVLADLRSWAAEYPQVLEATPIEALAISTAAISPWRGANELRLSAPDVRCGPTPLDDHVEQNVRSLDELDDLFGRCEAIVRGGDRDDGHPLLASLSGWQSALERAPHYPKLAGLWGDRFAEALRGERYDWTAGLARDRGEGPSDPQEYLTYAASSNAWITHFPRWATSDRDDLLDGLPVLDNALEAIEVAVRLSNDLATFERERAEPGQNNILMYDTSPDWVHDELDRHSRKAQEQLDPLATAGFPPAVELLRLLDWSVTFYSGADFRGWGSDRDLTGPSGLPSDM	MIGSLTARIFAIFWLTLALVLMLVLMLPKLDSRQMTELLDSEQRQGLMIEQHVEAELANDPPNDLMWWRRLFRAIDKWAPPGQRLLLVTTEGRVIGAERSEMQIIRNFIGQADNADHPQKKKYGRVELVGPFSVRDGEDNYQLYLIRPASSSQSDFINLLFDRPLLLLIVTMLVSTPLLLWLAWSLAKPARKLKNAADEVAQGNLRQHPELEAGPQEFLAAGASFNQMVTALERMMTSQQRLLSDISHELRTPLTRLQLGTALLRRRSGESKELERIETEAQRLDSMINDLLVMSRNQQKNALVSETIKANQLWSEVLDNAAFEAEQMGKSLTVNFPPGPWPLYGNPNALESALENIVRNALRYSHTKIEVGFAVDKDGITITVDDDGPGVSPEDREQIFRPFYRTDEARDRESGGTGLGLAIVETAIQQHRGWVKAEDSPLGGLRLVIWLPLYKRS	BGC0000286.1|Viguiepinol_3#2990#3877#1#ID=1_3;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.700	gnl|BL_ORD_ID|525|hsp_num:0	152
BGC0000286.1|Viguiepinol_6	ID=1_6;partial=00;start_type=ATG;rbs_motif=AGGAGG;rbs_spacer=5-10bp;gc_cont=0.725	6378	7430	+	Loose	n/a	0.0818157	MexB	25.0	ARO:3000378, ARO:3002804, ARO:3003056, ARO:3003056	FosA2, smeE, MexB	protein homolog model	n/a	efflux pump complex or subunit conferring antibiotic resistance	antibiotic inactivation enzyme; determinant of fosfomycin resistance; efflux pump complex or subunit conferring antibiotic resistance	2070	30.8018	30.8018, 24.6386, 25.0238, 24.6386	ATGTCTGAGCAACAGATCGCCGTCCTCCGCCCGCGGGAACAGCCGGGTGCGAACGGGGTCACCGCCGTCGCGCAGCCGAACATCGCGCTGATCAAGTACTGGGGGAAGCGGGACGAGCACCTCTTCCTCCCGTGGACCAGCAGCCTGTCGATGACCCTGGACATCTTCCCCACGACCACCCGTGTCCACCTCGACGCCGAGGCCACGGACGACGAAGTGACCTTCAACGGCGCACCCGCGGCGGGCGAAGAACGGCGGCGCATCACCGGATTCCTCGATCTGGTGCGCCAACGGGCCGGGCTCACGCACCGGGCCGTCGTCGACACCCGCAACACCGTGCCCACCGGGGCGGGCCTCGCGTCCTCCGCCGGCGGGTTCGCCGCACTCGCCGTCGCCGCCGCCACCGCGTACGGACTGGACCTCGACGACACCGGTCTCTCCCGCCTGGCCCGCCGCGGCTCCGGCTCGGCCTCGCGGTCGATCTTCGGCGGCTTCGCCGTCTGGAACGCCGGCACTCCCACGGCGCCCCCTGCGGAGGCCGACCTCAGCTCCTACGCGGAGCCGGTACCTGTGGGCGACCTCGACCCCGCACTGGTCATCGCGGTGGTGAACGCCGGTCCCAAGGACGTGTCCAGCCGCGCGGCCATGCGCCGAACCGTCGAGACCTCACCCCTGTTCGAGCCCTGGGCCGCGTCGAGCCGGGACGACCTGACCGAGATGAGACAGGCGCTCCTGCGCGCCGACCTCGACGCGGTGGGCGAGATCGCCGAGCGCAACTCGCTCGGCATGCACGCGACCATGCTGAGCGCGCGCCCTGCGGTGCGCTACCTCTCGCCCGCCTCGCTCACCGTCCTCGACAGCGTGCTGCGGCTTCGGCGCGACGGCATATCGGCCTACGCGACCATGGACGCCGGACCGAATGTCAAGGTGCTCTGCCGTCGTGCGGACGCCGACCTGGTCGCCGAGGCCGTGCGCGCCGCCGCCGCGGGCGGCACCGTGCACATCGCCGGGACGGGGCAGGGCGCCCGCCTGATCGACGAGGACGGACGATGA	MSEQQIAVLRPREQPGANGVTAVAQPNIALIKYWGKRDEHLFLPWTSSLSMTLDIFPTTTRVHLDAEATDDEVTFNGAPAAGEERRRITGFLDLVRQRAGLTHRAVVDTRNTVPTGAGLASSAGGFAALAVAAATAYGLDLDDTGLSRLARRGSGSASRSIFGGFAVWNAGTPTAPPAEADLSSYAEPVPVGDLDPALVIAVVNAGPKDVSSRAAMRRTVETSPLFEPWAASSRDDLTEMRQALLRADLDAVGEIAERNSLGMHATMLSARPAVRYLSPASLTVLDSVLRLRRDGISAYATMDAGPNVKVLCRRADADLVAEAVRAAAAGGTVHIAGTGQGARLIDEDGR	MSKFFIDRPIFAWVIALVIMLAGGLSILSLPVNQYPAIAPPAIAVQVSYPGASAETVQDTVVQVIEQQMNGIDNLRYISSESNSDGSMTTTVTFEQGTDPDIAQVQVQNKLQLATPLLPQEVQRQGIRVTKAVKNFLMVVGVVSTDGSMTKEDLSNYIVSNIQDPLSRTKGVGDFQVFGSQYSMRIWLDPAKLNSYQLTPGDVSSAIQAQNVQISSGQLGGLPAVKGQQLNATIIGKTRLQTAEQFENILLKVNPDGSQVRLKDVADVGLGGQDYSINAQFNGSPASGIAIKLATGANALDTAKAIRQTIANLEPFMPQGMKVVYPYDTTPVVSASIHEVVKTLGEAILLVFLVMYLFLQNFRATLIPTIAVPVVLLGTFGVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVMAEEGLSPREAARKSMGQIQGALVGIAMVLSAVFLPMAFFGGSTGVIYRQFSITIVSAMALSVIVALILTPALCATMLKPIEKGDHGEHKGGFFGWFNRMFLSTTHGYERGVASILKHRAPYLLIYVVIVAGMIWMFTRIPTAFLPDEDQGVLFAQVQTPPGSSAERTQVVVDSMREYLLEKESSSVSSVFTVTGFNFAGRGQSSGMAFIMLKPWEERPGGENSVFELAKRAQMHFFSFKDAMVFAFAPPSVLELGNATGFDLFLQDQAGVGHEVLLQARNKFLMLAAQNPALQRVRPNGMSDEPQYKLEIDDEKASALGVSLADINSTVSIAWGSSYVNDFIDRGRVKRVYLQGRPDARMNPDDLSKWYVRNDKGEMVPFNAFATGKWEYGSPKLERYNGVPAMEILGEPAPGLSSGDAMAAVEEIVKQLPKGVGYSWTGLSYEERLSGSQAPALYALSLLVVFLCLAALYESWSIPFSVMLVVPLGVIGALLATSMRGLSNDVFFQVGLLTTIGLSAKNAILIVEFAKELHEQGKGIVEAAIEACRMRLRPIVMTSLAFILGVVPLAISTGAGSGSQHAIGTGVIGGMVTATVLAIFWVPLFYVAVSTLFKDEASKQQASVEKGQ	BGC0000286.1|Viguiepinol_6#6379#7431#1#ID=1_6;partial=00;start_type=ATG;rbs_motif=AGGAGG;rbs_spacer=5-10bp;gc_cont=0.725	gnl|BL_ORD_ID|882|hsp_num:0	1925
BGC0000286.1|Viguiepinol_11	ID=1_11;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.698	11990	12970	+	Loose	n/a	0.296698	abeM	28.3	ARO:3000753	abeM	protein homolog model	n/a	efflux pump complex or subunit conferring antibiotic resistance	efflux pump complex or subunit conferring antibiotic resistance	850	28.8758	28.8758	ATGACCGACCTCAGGATTCTCGGTACGGGTGCCTATGTGCCGGAGCGAATCGCGTCCAATGACGAGGTCGCCGCGGCGGCGGGGGTCGACGACGCGTGGATCACCGCCAAGACCGGCATCCGGGAACGGCGATGGGCTGCCGACGACCAGGCCACCTCGGACCTGGCCACCGCCGCGGGGCGGGCCGCGCTGCGGTCGGCCGGCATCACCGCCGAGGACCTGTCCGTGATCGTGGTCGCCACGTCCACACCCGACCGGCCCCAACCGCCCACCGCCGCCTACGTCCAGCAGCGGCTCGGCGCGAGCGACGCGGCCGCGTTCGACGTCAACGCGGTCTGCTCCGGCATGGTGTTCGCGCTCGCCGCGGCCGAGGGCGTACTCACCCGCACCGGCGGCCACGCACTGGTCATCGGCGCGGACCTGTATTCCCGCATCCTGAACCGGGCCGACCGCAGGACCGTGATCCTTTTCGGGGACGGTGCCGGAGCGGTGATCCTGGGGTCGTCGGTCGACCACGGACCACGTATCCGGCACCTCGCGCTGCACTCGTTCGGCGAACTGTCGGGGCTCATCGAGGTGCCCGCCGGCGGCAGTCGCATGCCCGTGGACCAGACAGTCCTCGACGCAGGGCTTCAGTACTTCGCGATGGACGGGCGAGGCGTGCGGAACTTCGTCTGTGACCACCTGCCGCAGCTGGTCAAGGGATTCCTGCACAAATGCGGTGTCGTACCCGACGACATCGACCACTTCGTACCGCACCAGGCCAACGGCACCATGCTGGACAGCCTCTTCGCCGATTTGGAACTGCCTCGCGCGACCATGCACCGCACACTGACGCACTACGCCAACACGGGAGCCGCCTCCATCCCGATCACCCTGGACGCGGCCGCCCGCGCCGGCGCCTTCAACCCCGGCGACCTGATCCTCATGGCCGGCTTCGGCGGCGGCATGTCGGCGGGATTCGCGCTGGTCGAGTGGTGA	MTDLRILGTGAYVPERIASNDEVAAAAGVDDAWITAKTGIRERRWAADDQATSDLATAAGRAALRSAGITAEDLSVIVVATSTPDRPQPPTAAYVQQRLGASDAAAFDVNAVCSGMVFALAAAEGVLTRTGGHALVIGADLYSRILNRADRRTVILFGDGAGAVILGSSVDHGPRIRHLALHSFGELSGLIEVPAGGSRMPVDQTVLDAGLQYFAMDGRGVRNFVCDHLPQLVKGFLHKCGVVPDDIDHFVPHQANGTMLDSLFADLELPRATMHRTLTHYANTGAASIPITLDAAARAGAFNPGDLILMAGFGGGMSAGFALVEW	MSNVTSFRSELKQLFHLMLPILITQFAQAGFGLIDTIMAGHLSAADLAAIAVGVGLWIPVMLLFSGIMIATTPLVAEAKGARNTEQIPVIVRQSLWVAVILGVLAMLILQLMPFFLHVFGVPESLQPKASLFLHAIGLGMPAVTMYAALRGYSEALGHPRPVTVISLLALVVLIPLNMIFMYGLGPIPALGSAGCGFATSILQWLMLITLAGYIYKASAYRNTSIFSRFDKISLTWVKRILQLGLPIGLAVFFEVSIFSTGALVLSPLGEVFIAAHQVAISVTSVLFMIPLSLAIALTIRVGTYYGEKNWASMYQVQKIGLSTAVFFALLTMSFIALGREQIVSVYTQDINVVPVAMYLLWFAMAYQLMDALQVSAAGCLRGMQDTQAPMWITLMAYWVIAFPIGLYLARYTDWGVAGVWLGLIIGLSIACVLLLSRLYLNTKRLSQT	BGC0000286.1|Viguiepinol_11#11991#12971#1#ID=1_11;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.698	gnl|BL_ORD_ID|2275|hsp_num:0	1368
BGC0000286.1|Viguiepinol_1	ID=1_1;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.683	149	1405	+	Loose	n/a	5.38412	smeF	42.55	ARO:3003057	smeF	protein homolog model	n/a	efflux pump complex or subunit conferring antibiotic resistance	efflux pump complex or subunit conferring antibiotic resistance	890	25.409	25.409	ATGGGTCCCGACGACGCCTATGTGCCCTGCGATCCCGCCCTGTTCCGGCAGATACTCAAGGACACCCGGCTCTACGACAAGGGCGGCCTGTTCTACGATCGGGGCCGCGAGGCCGTGGGAAACGGCCTGGTCACCAGTCGCTGGGCCGATCACCGTCGGCAACGCCCGCTGATGCAGCCGTCGTTCGACCACCGGCACATCGGCCACTACGCCGAACTGATGGCGGACGAGACGGAAGCCCTGATGCGCTCCTGGCGATCGGGCGAGGTCGTCGACGTCGACAAGGCGATGGCAAGACTCACTCTTCGCATCACGACCAGATCCCTTTTCTCGGTGCCCGCGGACCACACGTTGGTGGCCCAGGTGGAGAAATGGCTGCCGATTCTCATGGACGGCTTCTTCCGGCGCATGTTCGTGCCGGCGCGGGTTCTCTCGCTCGTTCCCGGGAAGATGAACCGGCAATACCCCCCCCCCATCGCGGAGATGCGCAAGCTCACCGAAGAGATCATCGACGAGGTGCGGCGCAAGAAGGACGAGGACCCCGGCCTGCTCGCGGGCCTGATGAACGCGCGCGACGAGACCACCGGGGCCCCGCTCGGAACGCAGGAGATCTTCGACCAGGTCCTGATCCTGCTGATCGCCGGGTCGGAGACCACCGCGACGGCGCTGGCGTTCACCTTCCATCTGCTCGGCGCGCACCCCGAGATCGGCGCCCGCCTGCGGGAGGAGGTCGACGGCGCGCTCGGCGGCCGGACGCCCCGCTTCGAGGATCTCTCCGGGCTGACGTTCACGAGGCAGGTGCTCATGGAGAGCCTTCGCCTCTATCCGCCGGCGTGGATGTTCACCCGGTCCACCACCACGGCCTGCGAACTCGGCGGGCACGCGTTCCCCGAGGGAACCACCTTCCTGCTCAGCCCCTACATCCTGCAGCACGACCCGGAGTTGTTCCCCCGGCCGGAGAGGTTCGATCCGGATCGCTGGCGGCCCGGCGCGATGAGCGACGTCGCACGCCGGTCGGTGCTGCCCTTCGGCGCGGGCGGCAGGAAGTGCATCGGCGACCAGTTCGCGCTCAACGAGGCGATGTTGGCCGTCGCGGCGATCGCCGGCCGCTGGAACCTGACCCCCGTCGGTGACCGGCCGATACGGCCCATCGCCCGCGCCACGCTCAAGACGGGCCCTCTTCCGATGAGGCTCCAGGAGCGCCCGCACGAACCGGTGCGGAATGCGACGACCACCGATCTCCGAGACCAGAGGTAG	MGPDDAYVPCDPALFRQILKDTRLYDKGGLFYDRGREAVGNGLVTSRWADHRRQRPLMQPSFDHRHIGHYAELMADETEALMRSWRSGEVVDVDKAMARLTLRITTRSLFSVPADHTLVAQVEKWLPILMDGFFRRMFVPARVLSLVPGKMNRQYPPPIAEMRKLTEEIIDEVRRKKDEDPGLLAGLMNARDETTGAPLGTQEIFDQVLILLIAGSETTATALAFTFHLLGAHPEIGARLREEVDGALGGRTPRFEDLSGLTFTRQVLMESLRLYPPAWMFTRSTTTACELGGHAFPEGTTFLLSPYILQHDPELFPRPERFDPDRWRPGAMSDVARRSVLPFGAGGRKCIGDQFALNEAMLAVAAIAGRWNLTPVGDRPIRPIARATLKTGPLPMRLQERPHEPVRNATTTDLRDQR	MEVIPMKSASLFLSIAATLALAGCSTLAPKNTAVAPAIPAQWPAEAAQGEVADVAAVGWRDFFTDARLQQVIEQSLQNNRDLRVAVLNVERARGQYRVQRADRVPGVAVTGQMDRRGTDAGVTEQFSAGVGVAEFELDLFGRVRNLSEAALQQYFAVAANRRNAQLSLVAETATAWLTYGADAQRLKIADATLKTYEDSLRLAEARHERGGSSALELTQTRTLVETARTDAARLRGQLAQDRNALALLAGGQLDPALLPDSIEPQLLALAPPPAGLPSDVLLQRPDIMAAEHQLLAANANIGAARAAFFPSISLTGSIGSGSSELSNLFDSGTRVWSFLPKITLPIFQGGKLRANLAIANADRDIALAQYEKSIQVGFRETADALALNVSLDEQVSSQQRLVEAAEQANRLSQARYDAGLDSFVTLLDARRTAYNAQQTQLQAQLAQQANRITLYKVLGGGWHERG	BGC0000286.1|Viguiepinol_1#150#1406#1#ID=1_1;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.683	gnl|BL_ORD_ID|1119|hsp_num:0	634
BGC0000286.1|Viguiepinol_8	ID=1_8;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.712	8551	9642	+	Loose	n/a	6.39339	APH(3')-IIb	46.88	ARO:3002645, ARO:3000865	APH(3')-IIb, oleD	protein homolog model	n/a	antibiotic inactivation enzyme; determinant of aminoglycoside resistance	antibiotic inactivation enzyme; determinant of aminoglycoside resistance; determinant of macrolide resistance	700	24.6386	24.6386, 28.4906	ATGAGCGTTCAGCGCAAGGACGACCACGTCCGGCTCGCCATCGAGCAGCAGGACACCCGCAGCGGGATCAATCAGTTCGACGAGGTGTCCTTCGTACACCACGCCCTGGCCGGCATCGACCGGCCGCAGGTGTCCCTGGGCACGAGCTTCGCCGGGATCTCCTGGCAGGTGCCGCTCTACATCAACGCGATGACCGGCGGCACCGCCAGGACCGGCGTCATCAACCGGGGCCTGGCGACGGCCGCCCGCGAGACCGGGGTACCCCTCGCGTCGGGCTCCGTGCACGCCTACCTCAAGGACCCGACGTGCGCCGACACCTTCCGCGTCCTGCGCCGGGAGAACCCCCACGGGTTCGTCATGGCCAACGTGAACGCGACGGCATCGGTCGCCGACACCCGGCGTGCCATCGATCTGCTGGAGGCCGACGCCCTGCAGATCCACGTCAATACGGCGCAGGAGACGGCGATGCCGGAGGGCGACCGGTCCTTCGGATCCTGGGTCTCGCAGATCGAGAAGATCACGGCGGCCGTCGACCTGCCCGTGATCGTCAAGGAGGTCGGCAACGGCCTGAGCCGCGAGACCGTCCTGACGCTGCGACAGCTGGGTGTCAGCGTGGCGGACCTCGGCGGCCGGGGCGGCACCGACTTCGCCCGCATCGAGAACGGCCGGCGCCCGCTCGGCGACTACGCCTTCCTCCACGACTGGGGCCAGTCCACCGCCGCCTGCCTCCTGGACGCGCAGGGCGCCGGTCTCCCCGTGCTCGCCTCCGGCGGCGTCCGCCATCCCCTCGACGCCGCCCGAGCCCTGGCCTTGGGCGCCTCCGGCGTCGGGGCCTCCGGAGTGTTCCCGCGCACCCTGCTCGACGGCGGTGTCGAGGCGCTGATCGCACAGATCACGAACTGGCTGGACCAGCTCGCGGCCCTGCAGACCATGCTCGGCGCACGCACCCCCGCCGAGCTCGCGAGCAAGGACCTGCTGATCCACGGCACCCTGCGAACCTTCTGCGCCGACCGGGACATCGACGCGGGGCGACTCGCCCGGCGTACCCGATCGGCCGACGCCCTCCACGATTCGACGGGAAGAGCACGATGA	MSVQRKDDHVRLAIEQQDTRSGINQFDEVSFVHHALAGIDRPQVSLGTSFAGISWQVPLYINAMTGGTARTGVINRGLATAARETGVPLASGSVHAYLKDPTCADTFRVLRRENPHGFVMANVNATASVADTRRAIDLLEADALQIHVNTAQETAMPEGDRSFGSWVSQIEKITAAVDLPVIVKEVGNGLSRETVLTLRQLGVSVADLGGRGGTDFARIENGRRPLGDYAFLHDWGQSTAACLLDAQGAGLPVLASGGVRHPLDAARALALGASGVGASGVFPRTLLDGGVEALIAQITNWLDQLAALQTMLGARTPAELASKDLLIHGTLRTFCADRDIDAGRLARRTRSADALHDSTGRAR	MHDAATSMPPQAPSTWADYLAGYRWRGQGEGCSAATVHRLEAARRPTLFVKQEVLSAHAELPAEIARLRWLHGAGIDCPQVLNETQSDGRQWLLMSAMPGDTLSALAQRDELEPERLVRLVAAALRRLHDLDPAACPFDHRLERRLDTVRQRVEAGLVDEADFDDDHRGRSATELYRLLLDRRPAVEDLVVAHGDACLPNLLAEGRRFSGFIDCGRLGVADRHQDLALAARDIEAELGAAWAEAFLVEYGGDIDGERLAYFRLLDEFF	BGC0000286.1|Viguiepinol_8#8552#9643#1#ID=1_8;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.712	gnl|BL_ORD_ID|1684|hsp_num:0	954
BGC0000286.1|Viguiepinol_5	ID=1_5;partial=00;start_type=ATG;rbs_motif=3Base/5BMM;rbs_spacer=13-15bp;gc_cont=0.708	5354	6385	+	Loose	n/a	0.699889	vgaALC	30.86	ARO:3002830, ARO:3002829, ARO:3003010, ARO:3003067, ARO:3003036	oleB, vgaALC, ceoB, smeS, vgaA	protein homolog model	n/a	efflux pump complex or subunit conferring antibiotic resistance	efflux pump complex or subunit conferring antibiotic resistance; protein(s) and two-component regulatory system modulating antibiotic efflux	1100	27.7202	27.7202, 27.7202, 25.409, 24.2534, 26.1794	ATGAAATTTCGACAAGGGGAGCTGAATACGTCGACTCCACCGGCCTCGGTGGCGGGGACAGCGGAAAGCCGCCGCGCCCGCTCGGTCGGCACCGGCCGCGCCCACGCCAAGTCCATTTTGCTGGGGGAGCACGCGGTCGTCTACGGAGCCCCGGCGCTCGCCCTGCCCGTTCCGCAGCTGTCGATCACCGCCAGCGCCGGGTTCTCCAACCGCGGTGGGGAAGCGGCCGGCGTGTCCTTCACGATGACCGGATCCGCCTGGAAGCAGGTCGGAACGCAGGCATCCGAGGGGCTGCGCCGGCTGACCACCGACTTCAGGGCGTCCATGGGCATCGACGAGGGACCGCACCTCGATGTGATCATCGACGGTTCCATCCCGCTCGGCAGGGGACTTGGCTCCAGCGCGGCCTGCGCCCGTGCCGTCGTCCTCGCCCTGGCCGACCTCTGCGGCCGCGAGGTCTCGCAGCGGACGACGTTCGACCTGGTGCAGACCGCCGAGAACGTGATGCACGGCAAGGCCAGCGGCGTCGACGCCGTCACCGTGGGCGCGAGCGCCCCGTTGCTGTTCCAGGCGGGCGAGGCCCGCACGCTGCGTGTCGGCTGCGACGCGCTGTTCGTCATCGCGGACAGCGGCGCCGTCGGCAGCACCAAAGAAGCGGTCGACAAACTGCGGGAGAGGTTCCGGCTCCACGCCGGAACACAGGAGAGGTTCGTACGCCGGGCGTCGGAACTGACTGGCGAACCGGTGGCCGCCCTCGCCGCCGGCCAGCCGGAGGAGCTCGGCTCCCTGCTGACGGAGTACCACGGACTGCTCCGCGAGGCCGGGCTGAGCACCGACCGGATCGAGGCGATGGTGAGTGCCGCGCTCGCCGCAGACAGCCTCGGCGCCAAGATCACCGGCGGCGGACTGGGCGGCTGCGTCCTTGCGCTGACCCAGCCCGAGCAGGCGAGAGAGGTCACCCGGCGGCTGCACGAAGCGGGGGCCGTGCAGACGTGGATCGTCCCGCTGAGGAGGCTCGTCACTCATGTCTGA	MKFRQGELNTSTPPASVAGTAESRRARSVGTGRAHAKSILLGEHAVVYGAPALALPVPQLSITASAGFSNRGGEAAGVSFTMTGSAWKQVGTQASEGLRRLTTDFRASMGIDEGPHLDVIIDGSIPLGRGLGSSAACARAVVLALADLCGREVSQRTTFDLVQTAENVMHGKASGVDAVTVGASAPLLFQAGEARTLRVGCDALFVIADSGAVGSTKEAVDKLRERFRLHAGTQERFVRRASELTGEPVAALAAGQPEELGSLLTEYHGLLREAGLSTDRIEAMVSAALAADSLGAKITGGGLGGCVLALTQPEQAREVTRRLHEAGAVQTWIVPLRRLVTHV	MKILLEGLHIKHYVQDRLLLNINRLKIYQNDRIGLIGKNGSGKTTLLHILYKKIVPEEGIVKQFSHCELIPQLKLIESTKSGGEVTRNYIRQALDKNPELLLADEPTTNLDNNYIEKLEQDLKNWHGAFIIVSHDRAFLDNLCTTIWEIDEGRITEYKGNYSNYVEQKELERHREELEYEKYEKEKKRLEKAINIKEQKAQRATKKPKNLSSSEGKIKVTKPYFASKQKKLRKTVKSLETRLEKLERVEKRNELPPLKMDLVNLESVKNRTIIRGEDVSGTIEGRVLWKAKSFSIRGGDKMAIIGSNGTGKTTFIKKIVHGNPGISLSPSVKIGYFSQKIDTLELDKSILENVQSSSQQNETLIRTILARMHFFRDDVYKPISVLSGGERVKVALTKVFLSEVNTLVLDEPTNFLDMEAIEAFESLLKEYNGSIIFVSHDRKFIEKVATRIMTIDNKEIKIFDGTYEQFKQAEKPTRNIKEDKKLLLETKITEVLSRLSIEPSEELEQEFQNLINEKRNLDK	BGC0000286.1|Viguiepinol_5#5355#6386#1#ID=1_5;partial=00;start_type=ATG;rbs_motif=3Base/5BMM;rbs_spacer=13-15bp;gc_cont=0.708	gnl|BL_ORD_ID|530|hsp_num:0	159
BGC0000286.1|Viguiepinol_12	ID=1_12;partial=00;start_type=GTG;rbs_motif=GGxGG;rbs_spacer=5-10bp;gc_cont=0.658	13132	13245	+	Loose	n/a	6.00453	ErmU	80.0	ARO:3001305, ARO:3003099, ARO:3003094, ARO:3002666	rmtF, cphA2, imiH, ErmU	protein homolog model	n/a	antibiotic target modifying enzyme; determinant of lincosamide resistance; determinant of macrolide resistance; determinant of streptogramin resistance	antibiotic inactivation enzyme; antibiotic target modifying enzyme; determinant of aminoglycoside resistance; determinant of beta-lactam resistance; determinant of lincosamide resistance; determinant of macrolide resistance; determinant of streptogramin resistance	450	19.631	19.631, 19.631, 19.631, 21.1718	GTGGCGGAGAAGTTCGGCGGCGACTCGGTGCCCGAGACCCGGCGCAACGTCCAGTCGTACCTCGGCCAGGTGCCCCGGTACCCAATCGATTCCGAAGGCAAGGGGAACAAGTGA	VAEKFGGDSVPETRRNVQSYLGQVPRYPIDSEGKGNK	MPSRYGSRQDLGQNFLVDPDIIKLIRRAPNERKVPSLIWRRRGHVTLPLSRLGRPVTAVELDPRRVKRLSARAPENVKVVGEDILRFRLPTVPHTVVGNIPFHVTTATMRRILVAPAWVSAVLVVQWEVARRRAGIGGCSLVTAESWPWFDFSVLKRVPRFAFRPAPSVDGGILVIERRPEPLVRERREYQAFVRQVFTGRGHGLREILQRIGRVQDSDLSAWFRAHGVSPQALPKDLTAEQWASLWGMARGGRSVPRTRRPRGLPPRTSRGPRRNSG	BGC0000286.1|Viguiepinol_12#13133#13246#1#ID=1_12;partial=00;start_type=GTG;rbs_motif=GGxGG;rbs_spacer=5-10bp;gc_cont=0.658	gnl|BL_ORD_ID|2088|hsp_num:0	356
BGC0000286.1|Viguiepinol_17	ID=1_17;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.700	17858	18997	+	Loose	n/a	7.0999	ErmN	36.11	ARO:3000592, ARO:3002611	aadA11, ErmN	protein homolog model	n/a	antibiotic target modifying enzyme; determinant of lincosamide resistance; determinant of macrolide resistance; determinant of streptogramin resistance	antibiotic inactivation enzyme; antibiotic target modifying enzyme; determinant of aminoglycoside resistance; determinant of lincosamide resistance; determinant of macrolide resistance; determinant of streptogramin resistance	450	24.6386	24.6386, 24.2534	ATGACCGCGTCGGACCGTTCCCAGACGCGCCGTCGAAAGGTGCTGCTCGCACCCGTCACGGTTACCCCGGCCAAACCGCTCACACCCAGCCACCTCAAAGGTCTGCTGTGGACCGACGTCATGTTCCGGGCCACCGCGCCGCTCGCGGACGTGACCTACCGCTACAGCCCCACGACCTACCACCTCACCGAACAGACCCTAGGATTCTGGGAGTTCCTCGACCGCACGCAGAAGGGCCTGCCCTACGCCTCACTTTCCGAGGAGGAGATCGGCGAGCTGTACGTCCGGTTCCGGGCCTGCGCGCCCCCACCGGCCGACGCCTTGCGCCCCTACGCACACCAGGTCGAGAGCAACGGCTGGGTGCACCCGGCCAGTGAACGCGTTCTGCGCCTGTGGCGCGAGCACTACGCTCAACTCGGACTCCACGACCCTGGCCTGACGGTCCATCAACCGCCAGGGCTCGGCACGGAGGAGATGATCGAACGGCTCGTCGCCCTCGGCCTGGGGCTCGACCATCGCTCCAGCGGCGGTCCCGTGTACCTCGACGCCACTCGGCACGGTCTGCCCCTGCGCCAGATCGTGACGGCGGACGGCCGCCCGAACTACCTTGCCTGCGCCCTGCGGGAACTGCTTCCGCTGGCACCCGCGTATGACGAGGTCGTGCTCCTGTACGACACCGATCTCGACGCGGACTACCGGCTGCTGCAGCGCGCGCTGACCCAGCTGGGGCCGCTGGTGCACCGCGTCCCGATCGGTCGCGTGCCCATCGACGGCACGATCAGATCGGCGCGGCACGGCGGCTGGCACGCTTACACGGCGGGCGCCCTGCTCAAGGCCGTCGGCACGGAGGCCGACGCGGACGTACGCCGTCTCGGCGTACGGCTGTACTTCGTCGCCGTCCTCGGTCCCGGACAGGCGCAGTCCTTCCGCACCGACCTGCTTCACAGGAGCCTGGACCGGGCGCGGCAGCTGCTGCGCCGGACGACCGAGCGCGGGCCCGGCACTTCGCCTCTCGTGGACGACCTGCGCCGGCACCGGCGCGACCACACCCATGTCGATCCCTATCGGCTCACCTCGTCCCTGCTGGCCCGGGCCCGCCGCACCATCGACCGCGACCTGCTCTCCACGGTGTACCTATGA	MTASDRSQTRRRKVLLAPVTVTPAKPLTPSHLKGLLWTDVMFRATAPLADVTYRYSPTTYHLTEQTLGFWEFLDRTQKGLPYASLSEEEIGELYVRFRACAPPPADALRPYAHQVESNGWVHPASERVLRLWREHYAQLGLHDPGLTVHQPPGLGTEEMIERLVALGLGLDHRSSGGPVYLDATRHGLPLRQIVTADGRPNYLACALRELLPLAPAYDEVVLLYDTDLDADYRLLQRALTQLGPLVHRVPIGRVPIDGTIRSARHGGWHAYTAGALLKAVGTEADADVRRLGVRLYFVAVLGPGQAQSFRTDLLHRSLDRARQLLRRTTERGPGTSPLVDDLRRHRRDHTHVDPYRLTSSLLARARRTIDRDLLSTVYL	MPSRPRTDSPHRHEGPAGPARLDRDEARRVWGQNFFRSAGSARRFARQLTGAESAGNDSVTVEVGPGAGRITKELVRDGHPIVAVEVDPHWADRLAELELPNLTVVNDDFTTWPLPDGPLRFIGNLPFGTGTRMLRRCLALGPDRCREGVFLLQKQYTRKRTGAYGGNLFNAQWEPWYTFRRGLGFPRQEFAPVPGSDTETLLVRSRPRPLAPWSRHAAYQRFVEDVFNTSRLTIGEAARALDRRAGPGWLRGARVPPGLRVKDITAEQWADLFHACTPPPARRISPQRRR	BGC0000286.1|Viguiepinol_17#17859#18998#1#ID=1_17;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.700	gnl|BL_ORD_ID|2123|hsp_num:0	260
BGC0000286.1|Viguiepinol_7	ID=1_7;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.733	7427	8554	+	Loose	n/a	2.97409	FomB	41.18	ARO:3000449, ARO:3002909, ARO:3002893, ARO:3000865, ARO:3000533	FomB, macA, tcr3, oleD, vanG	protein homolog model	n/a	antibiotic inactivation enzyme; determinant of fosfomycin resistance	antibiotic inactivation enzyme; antibiotic resistance gene cluster, cassette, or operon; determinant of fosfomycin resistance; determinant of macrolide resistance; determinant of resistance to glycopeptide antibiotics; efflux pump complex or subunit conferring antibiotic resistance; protein(s) conferring antibiotic resistance via molecular bypass	760	25.7942	25.7942, 24.6386, 24.6386, 24.6386, 24.6386	ATGACCTCCGGGCGAACGGTCGTCCGCAGCGCGCCCGGCAAGCTGTTCGTCGCGGGCGAGTACGCGGTGGTGGAGCCCGGTACCCCGGCCGTCCTGGTGGCCGTGGACCGGGAGATCACCGTCATGGCGACCCTCTCCGACGCGGCCGACATCGTGATCTCCTCCGATCTCGTCCCCCGAGCGGTGACGTGGCGATGGCGCGACGGGCGGCTCCACGCGCCCGGCACGAAGAACGGGGACGCCGACGGGGACGGCGCACGCGGCGCACTGGCGCACGTGGTGTCAGCGGTCGAGACCGTGCGGAGACTCCTGGTCGAACGCGGCCTGCCCCTGCCCGGGCTGGAGATCTCGATCAGCAGCCGGCTGCACGACAACGGCCGCAAGTACGGCCTGGGGTCGAGCGGTGCGGTGACCGTGGCCACGATCGACGCCCTCACGTCCCTGTGCGGACTGGACCTCTCGCTCGACGCCCGGTACCGCCTGGCCGTGATCTCCTCGGCCGGGATCGACCCCAAGGGCTCCGGCGGTGACCTCGCCGCCAGTACATGGGGCGGCTGGATCGCGTACCAGGCACCCGACCGGGCCTTCGTGCTCGACCTCACCCGCCGCCACGGCATCGAGGAAGCGCTCCGCACCCCCTGGCCGGGCCTCGCGGTCCGAAGGCTTCCGGCCCCCCGCGGCCTCACCCTCGAAGTCGGCTGGACCGGCAGCCCGGCCTCGACCACCTCGCTCGTGTCCGGTCTGCACCGCCGGACCTGGCGCGGCACCGCCTCGCACCGCGCGTTCCTGGAGACCTCCACCGACTTCGTACGCGCCTCGATCACCGCCCTCGAGGCCGGCGACGACCAGAGCCTGCTGCGCCAGATCCGCCGTGCCCGGCAGGAGCTGGCCTGCCTCGACGACGAAGTCGGGCTCGGCATCTTCACACCCGAGCTGACGGCCCTGTGCGCGGTCGCCGAAACCGTCGGCGGCGCCGCCAAGCCGTCGGGCGCGGGCGGCGGCGACTGCGGCATCGCTCTGCTCGACGCCGAAGCCACGCACGACATCTCGCACGTACGGCAAGGGTGGGCCGCGGCCGGTGTGCTGGCCCTGCCCGTCCGGCCCGCCCCGAAAGGGATCGAGGAATGA	MTSGRTVVRSAPGKLFVAGEYAVVEPGTPAVLVAVDREITVMATLSDAADIVISSDLVPRAVTWRWRDGRLHAPGTKNGDADGDGARGALAHVVSAVETVRRLLVERGLPLPGLEISISSRLHDNGRKYGLGSSGAVTVATIDALTSLCGLDLSLDARYRLAVISSAGIDPKGSGGDLAASTWGGWIAYQAPDRAFVLDLTRRHGIEEALRTPWPGLAVRRLPAPRGLTLEVGWTGSPASTTSLVSGLHRRTWRGTASHRAFLETSTDFVRASITALEAGDDQSLLRQIRRARQELACLDDEVGLGIFTPELTALCAVAETVGGAAKPSGAGGGDCGIALLDAEATHDISHVRQGWAAAGVLALPVRPAPKGIEE	MLENLTIRSSRVVDLNLVKVRLSTNLEDFAAYSYFSAFAEDESAPADYEVVCVDLDRDDIPAELYADRTDRTFRGKRFKGGYYLVHYFGEPAHLITVGRTFYVFGRSLEKTVWPYFVKHILTVHSADHGFLHLKAAGFELPGAGATLLVGRNGAGKTVFLAQACLNGARFLSNTHTLVRDGVAHGVPSSIRVRRDQCFGELIDKHDLTAHMESGDYVTDSSTLFESPQISTARVRNVVIVDYDPARPQGLMPISPAAAGTFMEQFSFAVTTYGLKDDLLAHHGDFDTYVDSLARMRAQLTELVEGARCYRANADMLAKEVRDSTLKQLAE	BGC0000286.1|Viguiepinol_7#7428#8555#1#ID=1_7;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.733	gnl|BL_ORD_ID|1015|hsp_num:0	1850
BGC0000286.1|Viguiepinol_13	ID=1_13;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.678	13242	13871	+	Loose	n/a	1.8468	vanB	30.77	ARO:3000013, ARO:3003801	bcr-1, vanB	protein homolog model	n/a	determinant of resistance to glycopeptide antibiotics; protein(s) conferring antibiotic resistance via molecular bypass; antibiotic resistance gene cluster, cassette, or operon	antibiotic resistance gene cluster, cassette, or operon; determinant of resistance to glycopeptide antibiotics; efflux pump complex or subunit conferring antibiotic resistance; protein(s) conferring antibiotic resistance via molecular bypass	500	25.409	25.409, 23.483	GTGACAGACCGTCCGTTCTACGTGCTGCTGGGGCCGGACTACGCCGGGAAGTCCTCCGTGATGACGGAGCTCTCGGCGGCGATGCCCGGCTGGCAGACCCTGTCGACCGACGACGACCTCGTGGCCGGGGAGCACCGTCTGATCTCGCAGCTGCGCCGGAACGTCGTCCGGGACGTGCTGCCGGGCCTGGGGCCCACGTACTCCGCCGACTTCCTCGCGAGTCTGCTGGGCACGGCCGTCGTGCACCTGAGGGATCAGCTCGAACGGCAGGAGCCGGACGTGCCGGTCTTGATGGACTCGTACTACTACAAGATCCTCGCGAAGTGTCGACTCGCCGGGCTTGAAATGCACCCCCTGTACACCTGGTGGCGTTCCTTTCCCCTGCCGCGCGGAGTGATCTATCTGGACGTCTCGCCCGAGACCGCCTGGCGTCGCTCGGGACGCGGAGCGCAGCTCAACCCCCTCGAGCACTTCGGCGACCGGCCCGAGTGGTTCGGCTTCGAGAGCTATCAGAAGAACCTCGGCAAGCTGTTGCTGGAGGAAACGGGACAACTGCCCGTCACGGTGGTCGAGGAGCGGTCCGGGACGGCTGCGACCGCCGCGGCCGTGCGGGAGGTCCTGGCGGCATGA	VTDRPFYVLLGPDYAGKSSVMTELSAAMPGWQTLSTDDDLVAGEHRLISQLRRNVVRDVLPGLGPTYSADFLASLLGTAVVHLRDQLERQEPDVPVLMDSYYYKILAKCRLAGLEMHPLYTWWRSFPLPRGVIYLDVSPETAWRRSGRGAQLNPLEHFGDRPEWFGFESYQKNLGKLLLEETGQLPVTVVEERSGTAATAAAVREVLAA	MNRIKVAIIFGGCSEEHDVSVKSAIEIAANIDTEKFDPHYIGITKNGVWKLCKKPCTEWEADSLPAILSPDRKTHGLLVMKESEYETRRIDVAFPVLHGKCGEDGAIQGLFVLSGIPYVGCDIQSSAACMDKSLAYILTKNAGIAVPEFQMIDKGDKPEAGALTYPVFVKPARSGSSFGVTKVNGTEELNAAIEAAGQYDGKILIEQAISGCEVGCAVMGNEDDLIVGEVDQIRLSHGIFRIHQENEPEKGSENAMITVPADIPVEERNRVQETAKKVYRVLGCRGLARVDLFLQEDGGIVLNEVNTLPGFTSYSRYPRMMAAAGITLPALIDSLITLALKR	BGC0000286.1|Viguiepinol_13#13243#13872#1#ID=1_13;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.678	gnl|BL_ORD_ID|1611|hsp_num:0	1098
BGC0000286.1|Viguiepinol_15	ID=1_15;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.717	15565	16431	+	Loose	n/a	3.30928	AIM-1	50.0	ARO:3000853, ARO:3003923, ARO:3000808, ARO:3002891	AIM-1, oqxB, otr(A), MexI	protein homolog model	n/a	antibiotic inactivation enzyme; determinant of beta-lactam resistance	antibiotic inactivation enzyme; antibiotic target protection protein; determinant of beta-lactam resistance; determinant of tetracycline resistance; efflux pump complex or subunit conferring antibiotic resistance	1200	25.0238	25.0238, 27.335, 23.8682, 23.8682	ATGATGCATGTCCAGGATCCCGTCGACCCCGTGGAGACGACTGCCCTGCTGACCGCCGCCCTGCGCGCCGCCGAGAGCGGGCGGGAGGACCGGCTCTACAAGGATCCGTACGCGGCCGCGCTGGTGGGGGACGCAGGCCCCCGGCTCCTGGCGGAGATCCGTGCCGCGACCTTCCCGCCGGACGGGCCGCGGAGCGTGCCCAGTACCCCCGACTACAACGCGATCCGCACCAGATTCTTCGATGACCTCCTCCAAGAGGCCGTACAGGACCAGGGGATGACCCAGCTCGTCGTGGCCCCGGCCGGCATGGACTCCCGTGCCTACCGGCTGCCCTGGCCGCGACACCTGCGGTACTTCGAGGTCGACCGGCCGTCGGTGCTCGCGTTCAAGGAGGAGCGCCTGCGCGGGGTCGACCCGCGCGTCGACCACGTCACCGTCGCCGTCGACCTGACCGCGGACGACTGGGAGGACCGGCTCCGCGCCTCCGGATACGACCCGAGCACGCCGTCCACCTGGCTGCTCGAAGGGCTGCTGTACTACATCCCTGAGAAGGACACCGAGCGCATGCTGGAGCGGGTCGGCGCATTCTGTGCTCCGGGCAGCCGCATCGCCGCCGACCTCGTCAACTCCGCGGCCCTCACCCTCCCGCACATGCGTCCCCTCCTGGACGTCTTCAGCGGCTGGGGCTGCCCCTGGCTCTTCGGCAGCGACGAGCCCGAGGCGCTCTTCGAGCGGTACGGCTTCGACGTGGCCGCGGTCCAGCCCGGTGAGCCCGGGGCCCACTTCGGACGCTGGCCGGACCCGGTCCCCGACCGCGCCGTCAAGGACGTGCGGCGGGTGTTCTTCGTGCACGGCCAACGCCGGTGA	MMHVQDPVDPVETTALLTAALRAAESGREDRLYKDPYAAALVGDAGPRLLAEIRAATFPPDGPRSVPSTPDYNAIRTRFFDDLLQEAVQDQGMTQLVVAPAGMDSRAYRLPWPRHLRYFEVDRPSVLAFKEERLRGVDPRVDHVTVAVDLTADDWEDRLRASGYDPSTPSTWLLEGLLYYIPEKDTERMLERVGAFCAPGSRIAADLVNSAALTLPHMRPLLDVFSGWGCPWLFGSDEPEALFERYGFDVAAVQPGEPGAHFGRWPDPVPDRAVKDVRRVFFVHGQRR	MKRRFTLLGSVVALALSSTALASDAPASRGCADDAGWNDPAMPLKVYGNTWYVGTCGISALLVTSDAGHILVDAATPQAGPQILANIRALGFRPEDVRAIVFSHEHFDHAGSLAELQKATGAPVYARAPAIDTLKRGLPDRTDPQFEVAEPVAPVANIVTLADDGVVSVGPLALTAVASPGHTPGGTSWTWRSCEGDDCRQMVYADSLTAISDDVFRYSDDAAHPGYLAAFRNTLARVAALDCDILVTPHPSASGLWNRIGPRAAAPLMDTTACRRYAQGARQRLEKRLAEEAATSPSSGARP	BGC0000286.1|Viguiepinol_15#15566#16432#1#ID=1_15;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.717	gnl|BL_ORD_ID|1875|hsp_num:0	707
